Abstract
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant degenerative disease. Pathological studies have demonstrated not only cerebellar and brainstem atrophy, but substantia nigra, motoneurons, basal ganglia, thalamus, and peripheral nerves involvement. These findings may explain non-motor and extra-cerebellar features in SCA2. We accessed the non-motor symptoms and extra-cerebellar signs in SCA2 patients in order to provide a better understanding on pathophysiological mechanisms and natural history of brain degeneration in the disease. Thirty-three SCA2 patients were evaluated and compared with 26 healthy subjects. We investigated the following variables: sleep disorders, cognitive deficit, olfactory impairment, urinary dysfunction, psychiatric symptoms, cramps, pain, movement disorders, and weight loss. SCA2 had a high frequency of REM sleep behavior disorder (48.48 %, N = 16) as well as excessive daytime sleepiness (42.42 %, N = 14). Chorea was present in 15.15 % (N = 5), dystonia in 27.27 % (N = 9), and parkinsonism in 27.27 % (N = 9). Slow saccadic pursuit was present in 87.87 % (N = 29) and ophtalmoparesis in 78.78 % (N = 26) of patients. Regarding sleep disorders, 18.18 % (N = 6) of patients had restless leg syndrome. Dysphagia was present in 39.39 % (N = 13), weight loss 24.24 % (N = 8), and urinary dysfunction 27.27 % (N = 9). Cramps was present in only 6 % of patients (N = 2). This study highlighted the high frequency of non-motor symptoms and extra-cerebellar signs in SCA2. Our findings demonstrate the widespread of nervous system involvement in SCA2 patients and contribute to better understand the natural history of brain degeneration in this genetic condition.
Similar content being viewed by others
References
Schöls L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol. 2004;3:291–304.
Pedroso JL, França Jr MC, Braga-Neto P, D’Abreu A, Saraiva-Pereira ML, Saute JA, et al. Nonmotor and extracerebellar features in Machado-Joseph disease: a review. Mov Disord. 2013;28:1200–8.
Klinke I, Minnerop M, Schmitz-Hübsch T, Hendriks M, Klockgether T, Wüllner U, et al. Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6. Cerebellum. 2010;9:433–42.
Seidel K, Siswanto S, Brunt ER, den Dunnen W, Korf HW, Rüb U. Brain pathology of spinocerebellar ataxias. Acta Neuropathol. 2012;124:1–21.
Adanyeguh IM, Henry PG, Nguyen TM, Rinaldi D, Jauffret C, Valabregue R, et al. In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7. Mov Disord. 2015;30:662–70.
Pedroso JL, Bor-Seng-Shu E, Felício AC, Braga-Neto P, Hoexter MQ, Teixeira MJ, et al. Substantia nigra echogenicity is correlated with nigrostriatal impairment in Machado-Joseph disease. Parkinsonism Relat Disord. 2013;19:742–5.
Maas RP, van Gaalen J, Klockgether T, van de Warrenburg BP. The preclinical stage of spinocerebellar ataxias. Neurology. 2015;85:96–103.
Pedroso JL, Bor-Seng-Shu E, Braga-Neto P, Ribeiro RS, Bezerra ML, do Prado LB, et al. Neurophysiological studies and non-motor symptoms prior to ataxia in a patient with Machado-Joseph disease: trying to understand the natural history of brain degeneration. Cerebellum. 2014;13:447–51.
Lastres-Becker I, Rüb U, Auburger G. Spinocerebellar ataxia 2 (SCA2). Cerebellum. 2008;7:115–24.
Velázquez-Pérez L, Voss U, Rodríguez-Labrada R, Auburger G, Canales Ochoa N, Sánchez Cruz G, et al. Sleep disorders in spinocerebellar ataxia type 2 patients. Neurodegener Dis. 2011;8:447–54.
Valis M, Masopust J, Bažant J, Ríhová Z, Kalnická D, Urban A, et al. Cognitive changes in spinocerebellar ataxia type 2. Neuro Endocrinol Lett. 2011;32:354–9.
Velázquez-Pérez L, Fernandez-Ruiz J, Díaz R, González RP, Ochoa NC, Cruz GS, et al. Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases. J Neurol. 2006;253:1165–9.
Magaña JJ, Velázquez-Pérez L, Cisneros B. Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives. Mol Neurobiol. 2013;47:90–104.
Velázquez-Pérez L, Rodríguez-Labrada R, Cruz-Rivas EM, Fernández-Ruiz J, Vaca-Palomares I, Lilia-Campins J, et al. Comprehensive study of early features in spinocerebellar ataxia 2: delineating the prodromal stage of the disease. Cerebellum. 2014;13:568–79.
de Castilhos RM, Furtado GV, Gheno TC, Schaeffer P, Russo A, Barsottini O, et al. Spinocerebellar ataxias in Brazil—frequencies and modulating effects of related genes. Cerebellum. 2014;13:17–28.
Braga-Neto P, Godeiro-Junior C, Dutra LA, Pedroso JL, Barsottini OG. Translation and validation into Brazilian version of the Scale of the Assessment and Rating of Ataxia (SARA). Arq Neuropsiquiatr. 2010;68:228–30.
Schmitz-Hübsch T, Coudert M, Bauer P, Giunti P, Globas C, Baliko L, et al. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology. 2008;71:982–9.
Stiasny-Kolster K, Mayer G, Schafer S, Möller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire a new diagnostic instrument. Mov Disord. 2007;22:2386–93.
Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–5.
Silveira-Moriyama L, Carvalho Mde J, Katzenschlager R, Petrie A, Ranvaud R, Barbosa ER, et al. The use of smell identification tests in diagnosis of Parkinson’s disease in Brazil. Mov Disord. 2008;16:2328–34.
Rüb U, Farrag K, Seidel K, Brunt ER, Heinsen H, Bürk K, et al. Involvement of the cholinergic basal forebrain nuclei in spinocerebellar ataxia type 2 (SCA2). Neuropathol Appl Neurobiol. 2013;39:634–43.
Wu T, Wang C, Wang J, Hallett M, Zang Y, Chan P. Preclinical and clinical neural network changes in SCA2 parkinsonism. Parkinsonism Relat Disord. 2013;19:158–64.
Pedroso JL, de Freitas ME, Albuquerque MV, Saraiva-Pereira ML, Jardim LB, Barsottini OG. Should spinocerebellar ataxias be included in the differential diagnosis for Huntington’s diseases-like syndromes? J Neurol Sci. 2014;347:356–8.
van Gaalen J, Giunti P, van de Warrenburg BP. Movement disorders in spinocerebellar ataxias. Mov Disord. 2011;26:792–800.
Moro A, Munhoz RP, Moscovich M, Arruda WO, Raskin S, Teive HA. Movement disorders in spinocerebellar ataxias in a cohort of Brazilian patients. Eur Neurol. 2014;72:360–2.
Pedroso JL, Carvalho AA, Escorcio Bezerra ML, Braga-Neto P, Abrahão A, Albuquerque MV, et al. Unusual movement disorders in spinocerebellar ataxias. Parkinsonism Relat Disord. 2013;19:834–5.
Pedroso JL, Braga-Neto P, Felício AC, Minett T, Yamaguchi E, Prado LB, et al. Sleep disorders in Machado-Joseph disease: a dopamine transporter imaging study. J Neurol Sci. 2013;324:90–3.
Pedroso JL, Braga-Neto P, Felício AC, Aquino CC, Prado LB, Prado GF, et al. Sleep disorders in cerebellar ataxias. Arq Neuropsiquiatr. 2011;69:253–7.
Friedman JH, Fernandez HH, Sudarsky LR. REM behavior disorder and excessive daytime somnolence in Machado-Joseph disease (SCA-3). Mov Disord. 2003;18:1520–2.
Moscovich M, Munhoz RP, Teive HA, Raskin S, Carvalho Mde J, Barbosa ER, et al. Olfactory impairment in familial ataxias. J Neurol Neurosurg Psychiatry. 2012;83:970–4.
De Joanna G, De Rosa A, Salvatore E, Castaldo I, De Luca N, Izzo R, et al. Autonomic nervous system abnormalities in spinocerebellar ataxia type 2: a cardiovascular neurophysiologic study. J Neurol Sci. 2008;275:60–3.
Sánchez-Cruz G, Velázquez-Pérez L, Gómez-Peña L, Martínez-Góngora E, Castellano-Sánchez G, Santos-Falcón N. Dysautonomic features in patients with Cuban type 2 spinocerebellar ataxia. Rev Neurol. 2001;33:428–34.
Velázquez-Pérez L, Rodríguez-Labrada R, Canales-Ochoa N, Montero JM, Sánchez-Cruz G, Aguilera-Rodríguez R, et al. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study. Lancet Neurol. 2014;13:482–9.
Saute JA, Silva AC, Souza GN, Russo AD, Donis KC, Vedolin L, et al. Body mass index is inversely correlated with the expanded CAG repeat length in SCA3/MJD patients. Cerebellum. 2012;11:771–4.
Acknowledgments
Authors’ Contributions
1. Research project: A. Conception, B. Organization, C. Execution
2. Genetic evaluation: A. Execution
3. Clinical evaluation: A. Conception, B. Execution
4. Manuscript: A. Writing of the first draft, B. Review and Critique
Pedroso JL: 1A, 1B, 1C, 3A, 3B, 4A, 4B
Braga-Neto P: 1A, 1B, 1C, 3A, 3B, 4A, 4B
Bezerra MLE: 1A, 1B, 1C, 3A, 3B
Abrahão A: 1A, 1B, 1C, 3A, 3B
Albuquerque MVC: 1A, 1B, 1C, 3A, 3B
Rezende Filho FM: 3A, 3B, 4B
Souza PVS: 1A, 1B, 1C
Pinto WBVR: 1A, 1B, 1C
Borges Junior FRP: 1A, 1B, 1C, 3A, 3B
Saraiva-Pereira ML: 2A, 4A, 4B
Jardim LB: 2A, 4A, 4B
Barsottini OGP: 1A, 1B, 1C, 3A, 3B, 4A, 4B
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Full consent was obtained from the patients to be enrolled in this study. Our Institutional Ethics Committee approved this study.
Conflict of Interest
The authors declare that they have no competing interests.
Financial Disclosure
We have nothing to disclose.
Additional information
José Luiz Pedroso and Pedro Braga-Neto contributed equally to this work.
Rights and permissions
About this article
Cite this article
Pedroso, J.L., Braga-Neto, P., Escorcio-Bezerra, M.L. et al. Non-motor and Extracerebellar Features in Spinocerebellar Ataxia Type 2. Cerebellum 16, 34–39 (2017). https://doi.org/10.1007/s12311-016-0761-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12311-016-0761-5